ŌURA Files Confidential IPO After $900M Series E, Dexcom Ties CGM Data
ŌURA has confidentially filed SEC paperwork for an IPO after its $900M Series E financing at an $11B valuation and growth to over five million paid members. Dexcom’s $75M November 2024 investment to integrate CGM data with the Oura ring positions Dexcom to tap into wearable health metrics.
1. IPO Filing and Timeline
ŌURA has confidentially filed paperwork with the SEC for a proposed initial public offering of its common stock, with offering size, price range and timing to be determined after regulatory review and market conditions.
2. Series E Financing and Valuation
In October 2025 ŌURA closed a $900M Series E financing round at an approximate $11B valuation, laying the groundwork for its upcoming IPO.
3. Membership Growth
ŌURA announced it will surpass five million paid members this quarter, marking a fourfold increase in its subscriber base over the past two years.
4. Dexcom Partnership and Financials
Dexcom invested $75M in November 2024 to integrate its continuous glucose monitoring data with Oura ring metrics; ŌURA generated $500M in 2024 revenue and aims to surpass $1B in 2025.